4//SEC Filing
Bellerophon Therapeutics, Inc. 4
Accession 0001600132-16-000047
CIK 0001600132operating
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 3:39 PM ET
Size
5.6 KB
Accession
0001600132-16-000047
Insider Transaction Report
Form 4
Luehring Jens
Director10% Owner
Transactions
- Award
Common Stock
2016-04-28+19,860→ 19,860 total
Holdings
- 1,629,804(indirect: See footnote)
Common Stock
Footnotes (1)
- [F1]These shares are owned directly by Linde North America, Inc. ("Linde"). Jens Luehring is a director and chief financial officer of Linde. Mr. Luehring disclaims beneficial ownership of all shares held by Linde, except to the extent of his pecuniary interest therein.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001600132
Filing Metadata
- Form type
- 4
- Filed
- Apr 28, 8:00 PM ET
- Accepted
- Apr 29, 3:39 PM ET
- Size
- 5.6 KB